biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by Sniper007on Apr 10, 2014 7:17pm

271 Views

Post# 22437523

BiOasis' BT2111 is worth 60 Billion+ over ten years

Assuming success. If BTI's BT2111 captures the Herceptin market of 6 billion+ a year, the simple math is that it's potentially worth 60 billion over ten years. 60 Billion! BT2111 is only one of "hundreds" of potential conjugates. So, if BTI were to capture the 6 billion+ market per year, what would the stock price be worth today? Why is this stock stuck at 1.15? Financial market... Do the math! When they do do the math and "get it", say goodbye to these lows. Sounds like things are really heating up. Go BTI!!!!!!!!!!!!!!! On a side note, I called Liolios today regarding Drjeckyl's post but have not heard back from them.

Bullboard Posts

Canadian artificial intelligence ETFs